Ole­ma On­col­o­gy re­ceives $180M in to­tal fund­ing

Ole­ma On­col­o­gy, the Bay Area biotech run by for­mer As­traZeneca ex­ec­u­tive Sean Bo­hen, raised $130 mil­lion from a pri­vate place­ment and a cred­it fa­cil­i­ty of up to $50 mil­lion from Sil­i­con Val­ley Bank to ad­vance its breast can­cer treat­ment.

The biotech an­nounced Tues­day that it can re­ceive $25 mil­lion once the place­ment clos­es on Sept. 12, with the re­main­ing funds be­ing able to be with­drawn at SVB’s dis­cre­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER